The latest market intelligence report on the NEXT GENERATION SEQUENCING (NGS) market aims at exploring the unknown and coming up with solutions to the potential threats and challenges faced by the NEXT GENERATION SEQUENCING (NGS) market for the forecast period, 2019 - 2030.
High-throughput sequencing otherwise known as next-generation sequencing is revolutionizing microbiology and medicine with the continuous development of sequencing technologies, the cost for sequencing a human genome is continuously reducing. On breaking this barrier it is predicted that human genome sequencing will become common, which would help facilitate a brand new era in personalized medicine where genetic analyses will become central to understanding susceptibility to infectious diseases. These recent technologies allow DNA and RNA to be sequenced efficiently with lesser cost and time involved.
Access Full Sample PDF @ https://www.marketindustryreports.com/pdf/3
The growing adoption of Next-generation sequencing technologies in clinical applications in whole genomes or targeted genomes sequencing has driven the growth in the market. Next-generation sequencing has begun to be used in a variety of clinical applications due to the reduction of the overall cost of sequencing. The technology has clinical applications in fields like the identification of infectious diseases, inherited genetic disorders, cancer, and cancer-related disorders.
The next generation sequencing market can be segmented on the basis of region into Asia-Pacific, North America, Europe, and the Rest of the World (Latin America (LATAM), and the Middle East and Africa (MENA). North America dominated the next generation sequencing market quickly followed by Europe. The Asia-Pacific region, however, is likely to witness the highest growth due to factors such as the investment by pharmaceutical and biotechnology companies in drug discovery, technological advancement in NSG, the wide penetration of the technology and the increasing focus on drug discovery initiatives by healthcare and biopharmaceutical companies.
Read More : http://www.sbwire.com/press-releases/next-gen...221188.htm
Read More : http://www.digitaljournal.com/pr/4314281
Increasing Demand of NGS for Clinical Application
The advent of NGS has led to significant changes in the scientific approach utilized for both clinical and research applications. Both RNA & DNA sequencing have been proven to be extremely useful for studying evolutionary relationships, mutation, sequence variation and other vital information associated with genes. The clinical applications of which has been pivotal in diagnosing germline diseases and understanding the genetic basis of various hereditary or chronic diseases among others. The growing incidences of several clinical ailments has directly contributed to the extensive adoption of NGS and other sequencing techniques, to obtain better understanding of the diseases and formulate necessary therapies for the same.
Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Next generation sequencing (NGS) Market by Product & Services (Pre-Sequencing Products & Service, Sequencing Services, Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing), Application (Diagnostics, Drug Discovery), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers) - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/3/next-...NGS-market
Major Players in the Next generation sequencing (NGS) Market
The prominent players in the global Next generation sequencing (NGS) market are Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.
COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
10x Genomics
Agilent Technologies, Inc.
Beckman Coulter (A Subsidiary of Danaher)
Becton, Dickinson and Company
BGI
Eurofins Scientific
F. Hoffmann-La Roche AG
Genewiz
Illumina, Inc.
Macrogen, Inc (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
About Market Industry Reports-
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: sales@marketindustryreports.com
Phone: + 91 967353933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Face book
High-throughput sequencing otherwise known as next-generation sequencing is revolutionizing microbiology and medicine with the continuous development of sequencing technologies, the cost for sequencing a human genome is continuously reducing. On breaking this barrier it is predicted that human genome sequencing will become common, which would help facilitate a brand new era in personalized medicine where genetic analyses will become central to understanding susceptibility to infectious diseases. These recent technologies allow DNA and RNA to be sequenced efficiently with lesser cost and time involved.
Access Full Sample PDF @ https://www.marketindustryreports.com/pdf/3
The growing adoption of Next-generation sequencing technologies in clinical applications in whole genomes or targeted genomes sequencing has driven the growth in the market. Next-generation sequencing has begun to be used in a variety of clinical applications due to the reduction of the overall cost of sequencing. The technology has clinical applications in fields like the identification of infectious diseases, inherited genetic disorders, cancer, and cancer-related disorders.
The next generation sequencing market can be segmented on the basis of region into Asia-Pacific, North America, Europe, and the Rest of the World (Latin America (LATAM), and the Middle East and Africa (MENA). North America dominated the next generation sequencing market quickly followed by Europe. The Asia-Pacific region, however, is likely to witness the highest growth due to factors such as the investment by pharmaceutical and biotechnology companies in drug discovery, technological advancement in NSG, the wide penetration of the technology and the increasing focus on drug discovery initiatives by healthcare and biopharmaceutical companies.
Read More : http://www.sbwire.com/press-releases/next-gen...221188.htm
Read More : http://www.digitaljournal.com/pr/4314281
Increasing Demand of NGS for Clinical Application
The advent of NGS has led to significant changes in the scientific approach utilized for both clinical and research applications. Both RNA & DNA sequencing have been proven to be extremely useful for studying evolutionary relationships, mutation, sequence variation and other vital information associated with genes. The clinical applications of which has been pivotal in diagnosing germline diseases and understanding the genetic basis of various hereditary or chronic diseases among others. The growing incidences of several clinical ailments has directly contributed to the extensive adoption of NGS and other sequencing techniques, to obtain better understanding of the diseases and formulate necessary therapies for the same.
Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Next generation sequencing (NGS) Market by Product & Services (Pre-Sequencing Products & Service, Sequencing Services, Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing), Application (Diagnostics, Drug Discovery), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers) - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/3/next-...NGS-market
Major Players in the Next generation sequencing (NGS) Market
The prominent players in the global Next generation sequencing (NGS) market are Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.
COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
10x Genomics
Agilent Technologies, Inc.
Beckman Coulter (A Subsidiary of Danaher)
Becton, Dickinson and Company
BGI
Eurofins Scientific
F. Hoffmann-La Roche AG
Genewiz
Illumina, Inc.
Macrogen, Inc (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
About Market Industry Reports-
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: sales@marketindustryreports.com
Phone: + 91 967353933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Face book
